BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 12788799)

  • 1. Cardiovascular function in acromegaly.
    Clayton RN
    Endocr Rev; 2003 Jun; 24(3):272-7. PubMed ID: 12788799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The GH-IGF-I axis and the cardiovascular system: clinical implications.
    Colao A
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):347-58. PubMed ID: 18462260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of 1-year treatment with octreotide on cardiac performance in patients with acromegaly.
    Colao A; Cuocolo A; Marzullo P; Nicolai E; Ferone D; Florimonte L; Salvatore M; Lombardi G
    J Clin Endocrinol Metab; 1999 Jan; 84(1):17-23. PubMed ID: 9920056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cardiological findings in acromegaly].
    Ferramosca B; Bianchi D; Serra D; Savini R; Villecco AS; Bugiardini R
    Minerva Med; 1987 Dec; 78(24):1813-21. PubMed ID: 3431727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acromegaly and the cardiovascular system.
    Lombardi G; Galdiero M; Auriemma RS; Pivonello R; Colao A
    Neuroendocrinology; 2006; 83(3-4):211-7. PubMed ID: 17047385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular complications in acromegaly.
    Vitale G; Pivonello R; Lombardi G; Colao A
    Minerva Endocrinol; 2004 Sep; 29(3):77-88. PubMed ID: 15282442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac abnormalities in acromegaly. Pathophysiology and implications for management.
    Vitale G; Pivonello R; Lombardi G; Colao A
    Treat Endocrinol; 2004; 3(5):309-18. PubMed ID: 15330678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac effect of thyrotoxicosis in acromegaly.
    Marzullo P; Cuocolo A; Ferone D; Pivonello R; Salvatore M; Lombardi G; Colao A
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1426-32. PubMed ID: 10770177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular involvement in patients affected by acromegaly: an appraisal.
    Mosca S; Paolillo S; Colao A; Bossone E; Cittadini A; Iudice FL; Parente A; Conte S; Rengo G; Leosco D; Trimarco B; Filardi PP
    Int J Cardiol; 2013 Sep; 167(5):1712-8. PubMed ID: 23219077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone and the heart.
    Saccà L; Cittadini A; Fazio S
    Endocr Rev; 1994 Oct; 15(5):555-73. PubMed ID: 7843068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone, acromegaly, and heart failure: an intricate triangulation.
    Saccà L; Napoli R; Cittadini A
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):660-71. PubMed ID: 14974906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GH and IGF-I excess control contributes to blood pressure control: results of an observational, retrospective, multicentre study in 105 hypertensive acromegalic patients on hypertensive treatment.
    Colao A; Terzolo M; Bondanelli M; Galderisi M; Vitale G; Reimondo G; Ambrosio MR; Pivonello R; Lombardi G; Angeli A; degli Uberti EC
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):613-20. PubMed ID: 18410555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired cardiac performance is a distinct feature of uncomplicated acromegaly.
    Fazio S; Cittadini A; Cuocolo A; Merola B; Sabatini D; Colao A; Biondi B; Lombardi G; Saccà L
    J Clin Endocrinol Metab; 1994 Aug; 79(2):441-6. PubMed ID: 8045960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is growth hormone bad for your heart? Cardiovascular impact of GH deficiency and of acromegaly.
    Lombardi G; Colao A; Marzullo P; Ferone D; Longobardi S; Esposito V; Merola B
    J Endocrinol; 1997 Oct; 155 Suppl 1():S33-7; discussion S39. PubMed ID: 9389993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced nitric oxide levels in acromegaly: cardiovascular implications.
    Ronconi V; Giacchetti G; Mariniello B; Camilletti A; Mantero F; Boscaro M; Vignini A; Mazzanti L
    Blood Press; 2005; 14(4):227-32. PubMed ID: 16126556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular complications of acromegaly.
    Kamenický P; Maione L; Chanson P
    Ann Endocrinol (Paris); 2021 Jun; 82(3-4):206-209. PubMed ID: 33168155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The heart in acromegaly: an echocardiographic study].
    Kawanishi H; Suda K; Mori T; Chiba T; Matsuda Y; Inatome T; Inoh T; Yokota Y; Matsumoto K; Fukuzaki H
    J Cardiogr; 1984 Oct; 14(3):459-69. PubMed ID: 6242154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subclinical cardiac dysfunction in acromegaly: evidence for a specific disease of heart muscle.
    Rodrigues EA; Caruana MP; Lahiri A; Nabarro JD; Jacobs HS; Raftery EB
    Br Heart J; 1989 Sep; 62(3):185-94. PubMed ID: 2528980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormonal diagnosis of GH hypersecretory states.
    Grottoli S; Gasco V; Ragazzoni F; Ghigo E
    J Endocrinol Invest; 2003; 26(10 Suppl):27-35. PubMed ID: 15497657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.